ABSTRACT: During mouse embryogenesis striated muscle first becomes morphologxally distinguishable between 7.5 and 8.5 d post coitum (p.c.1. By 15 d P.c., embryonic skeletal muscle begins to differentiate into fast and slow fiber types, and, in the heart, atrial, ventricular, and conductive tissue myocytes have developed. These processes of muscle differentiation and maturation a t embryonic and fetal stages of development can be analyzed using in situ hybridization with gene-specific probes for mRNAs that are expressed in myocytes. Many cytoplasmic protein and nuclear protein genes that are expressed in muscle have been cloned. Comparison of the spatial and temporal patterns of expression of structural protein and transcription factor genes during myogenesis has given us insight into the cascade of cellular events that lead from a committed, dividing myoblast to a mature, terminally differentiated myocyte or myofiber. For example, cardiac and skeletal muscle express many of the same myosin and actin genes, particularly during embryonic development. However, the molecular mechanisms that regulate the expression of these genes is distinct in the two types of striated muscle, because the MyoD family of myogenic regulatory factors that are known to be important in skeletal muscle development have never been detected in cardiac muscle. Recently, several transcription factors have been cloned that are expressed in cardiogenic regions at 7.5 d P.c., suggesting that they are involved in the process of cardiac myocyte differentiation.
Introduction
Several breakthroughs in our understanding of muscle cell determination and differentiation in the mouse embryo have occurred in the last 7 yr. The first important discovery resulted from the cloning of the MyoD family of myogenic regulatory factors that play critical roles in skeletal muscle development (reviewed in Weintraub et al., 1991; Olson and Klein, 19941 . A second family of transcription factor genes, encoding the Myocyte Enhancer Factor 2 (MEFB) nuclear proteins, are also important in skeletal muscle development . Our understanding of the molecular mechanisms that control myogenesis have been further aided by the discovery of other types of nuclear proteins that have been implicated in the regulation of skeletal muscle development. Among J. Anim. Sci. 1996. 74(Suppl. 2):1-8 these are the proto-oncogenes, ski and sno (reviewed in Sutrave and Hughes, 19911 , and the homeoboxcontaining genes Engrailed-2 (Logan et al., 1993) and MHox (Cserjesi et al., 1992) .
Transcription factors that are thought to play a role in cardiac muscle development are MEF2 (Edmondson et al. 19941, GATA-4 (Arceci et al., 19931, mTEF-1 (Shimizu et al., 1993) and the homeobox-containing gene Nkx-2.5 (Lints et al., 1993) . All of these nuclear factors are thought to regulate the expression of muscle-specific genes in a cascade of events that lead to the development of mature rnyocytes in the mouse. The current models of action of these myogenic regulatory factors in the mouse embryo have been based partially on the spatial and temporal patterns of expression of these genes as analyzed by in situ hybridization.
Materials and Methods

Preparation of Tissue Sections Before Hybridization
The protocol used to fix and embed mouse embryos is described in Lyons et al. (1990a) . Post coital ( p.c.1 1 d .5 is counted as the morning when the vaginal plug is detected. Briefly, embryos are fixed in 4% paraformaldehyde in phosphate buffered saline ( P B S ) a t 4°C overnight on a rocker table, washed in PBS and saline buffer, dehydrated in a series of ethanols, and infiltrated with three changes of paraffin. Sections, each 5 to 7 pm thick, are mounted on subbed slides ( t h a t have one end frosted on both sides), deparafinized in xylene, and rehydrated rapidly through a series of ethanols and post-fixed for 20 rnin in 4% paraformaldehyde. Sections are washed twice in PBS and digested with proteinase K (20 pg/mL) for 15 min at RT, post-fixed in 4% paraformaldehyde for 5 min, acetylated with acetic anhydriddtriethanolamine for 10 min with stirring, washed with PBS and saline buffers, and dehydrated rapidly through a series of ethanols.
cRNA Probe Preparation
For gene-specific probes, coding and(or) noncoding regions of cDNAs of interest are chosen that have less than 80% homology to other genes. These cDNAs are subcloned into transcription vectors that contain RNA polymerase initiation sites a t either end of the cloning site. These cDNA inserts should be between 100 bp and 2 kbp. If the mRNA of interest is not very abundant, a longer probe is preferable. The cRNA transcripts are synthesized according to manufacturer's conditions (e.g., Stratagene) and labeled with 35S-UTP (>1,000 Ci/mmol Amersham). A second radioactive nucleotide, 35S-CTP, can be used to enhance hybridization signal. A nonradioactive thio-ATP (25 @, Boehringer Mannheim) can be added to the in situ hybridization buffer to reduce background by eliminating nonspecific sticking of the radioactive probe. Nonradioactive cRNA probes may also be synthesized with digoxigenin-UTP (Boehringer-Mannheim). Nonradioactive probes are generally less sensitive than radioactive probes and therefore are not often used to detect low-abundance mRNAs. The following probes were used for the Figures and are described in detail in the citations: 1) myogenin and MyoD (Sassoon et al., 1989) ; 2 ) beta myosin heavy chain, myosin light chain lventricular, myosin light chain lAtria1, perinatal myosin heavy chain (Lyons et al., 1990a,b) ; and 3 ) MEFBC, MEF2D (Edmondson et al., 1994) .
Hybridization and Washing Procedures
The hybridization and posthybridization procedures followed are described in Lyons et al. (1990a) . All probes are subjected to the same hybridization and washing conditions. Sections are hybridized overnight at 52°C in a humid chamber ( a 25 microslide box with a wet paper towel at the bottom that has been sealed with electrical tape) with 50,000 c p m /~L 35S-labeled ( 1 pg/mL Digoxigenin-labeled) cRNA probe in ET AL.
hybridization buffer (50% deionized formamide, .3 M NaC1, 20 mM Tris-HC1, pH 7.4, 5 mM EDTA, 10 d NaP04, 10% dextran sulfate, 1 x Denhardt's, 50 pg/ mL total yeast RNA). The tissues are subjected t o stringent washing a t 65°C in 50% formamide, 2x SSC, 10 mM DTT and washed in PBS before treatment at 37°C with 20 pg/mL RNAse A for 30 min. Following 15-minute washes in 2x SSC and . l x SSC at 37"C, the slides are rapidly dehydrated in a series of ethanols, dipped in full-strength Kodak NTB-2 nuclear track emulsion, and exposed for 1 to 2 wk in light-tight boxes with desiccant at 4°C. Photographic development is carried out for 3.5 min in full-strength Kodak D-19 at 16°C. Slides are fixed, rinsed, dehydrated through a series of ethanols, and lightly stained with toluidine blue ( o r a comparable histological stain). Sections hybridized with digoxigenin-labeled probes are treated with a n alkaline phosphatase-conjugated antibody to digoxigenin (Boehringer Mannheim) overnight. After extensive washing with buffers containing 2 mM levamisole (Sigma), the histochemical reaction for alkaline phosphatase is performed for 10 rnin to overnight. Slides are coverslipped and analyzed using both brightfield and darkfield optics of a high-quality microscope such as a Zeiss Axiophot. These and other in situ hybridization protocols are detailed in Wilkinson (1992) .
Results and Discussion
Skeletal Muscle Differentiafion in the Mouse Emb y o
Beginning at 8.0 d p.c. somites begin to form from the paraxial mesoderm on either side of the neural tube. Somites form in a rostrocaudal gradient as the embryo develops (Rugh, 1990; Kaufman, 1992) . Shortly aRer formation, the somites differentiate into two compartments, the sclerotome, which migrates ventrally to form the prevertebral cartilage, and the dermamyotome, which gives rise to two populations of myogenic cells. T h e first skeletal muscle to form in the embryo is the myotome compartment of the somite. These cells elongate in a craniocaudal direction underneath the dermatome. The second population of myogenic cells migrates out to the trunk, branchial arches, and limb buds (Wachtler and Christ, 1992) .
Each of the two muscle cell populations exhibits distinct temporal patterns of myogenic regulatory factor gene expression. Members of the MyoD family of transcription factor genes are upregulated in a distinct developmental sequence. As soon as a somite forms, myf-5 gene transcripts are detected by in situ hybridization in its craniomedial edge. This pattern of expression continues in the dermamyotome. When the myotome forms, myf-5 mRNAs become confined to these myogenic cells ( O t t et al., 1991) . Myogenin gene transcripts are not detected until myotomes begin to form a t 8.5 d p.c. MRF4 mRNAs are expressed in a transient fashion in myotomes between 9 and 10.5 d p.c. (Hinterberger et al., 1991) . MyoD is the last of the four multigene family members to be detected by in situ hybridization in myotomes (Sassoon et al., 1989 ; summarized in Table 1A ). In forelimb buds, myf-5 is the first muscle gene transcript detected at 10.5 d P.c., but 12 h later, myogenin and MyoD gene expression are both rapidly upregulated, and no transient expression of MRF4 is detected by in situ hybridization (reviewed in Lyons and Buckingham, 1992) .
MyoD-like factor gene transcripts are not detected in the second population of premyogenic cells as they migrate. Recently, Bober et al. (1994) have shown that Pax-3 is expressed in these cells. The homozygous splotch mouse embryo that does not form limb musculature has a mutation in the Pax-3 gene. Therefore, the expression of a functional Pax-3 protein seems to be necessary for premyogenic cell migration to the limb. In the limb buds of normal mouse embryos, the upregulation of myogenic regulatory factors is delayed by approximately 24 h (Sassoon et al., 1989) . This delay may be caused by the growth factor-rich environment into which the cells migrate, because growth factors are known to inhibit myogenic differentiation in vitro (reviewed in Florini et al., 1991) .
Both populations of myogenic cells, the myotomes and the cells that migrate to peripheral locations, are illustrated in Figure 1A . Myogenin gene transcripts are detected by in situ hybridization in myotomes and in premuscle masses of the mandibular arch at 11.5 d p.c. As the premuscle masses develop into discrete muscle groups at 13.5 d p.c. (Figure l B ) , myogenin mRNAs continue to be detected a t high levels in the intercostal and vertebral muscles that are myotome derivatives and in specific jaw muscles that are derived from the mandibular arch premuscle mass. This first phase of skeletal muscle development consists of primary myotubes, which have a uniform pattern of contractile protein gene expression (Lyons et al., 1990a) . Between 14 and 15 d p.c. secondary myotubes begin to form using primary myotubes as a scaffold (Ontell and Kozeka, 1984) . With the onset of this second phase of skeletal muscle development, distinct fiber types begin to appear. Figure 2 illustrates how the technique of in situ hybridization can be used to detect future fast and slow myofibers. At 15 d P.c., the tongue, which contains fast fibers in the adult mouse, and some jaw and pectoral muscles, which are mixed fast and slow muscles in the adult, are distinguishable with probes to different myosin mRNAs. (The embryonic pattern of expression of genes encoding different isoforms of myosin are summarized in Table 1B ). Perinatal myosin heavy chain ( Figure 2B ) and myosin light chain 1 (Figure  2 F ) fast gene transcripts are detected predominantly in future fast fibers, but myosin heavy chain beta ( Figure 2D ) and myosin light chain 1 slow ( Figure  2C ) mRNAs are restricted to future slow muscle fibers. At 15 d P.c., MyoD (Figure 2 E ) is expressed in both fast and slow myofibers, but in the adult this gene transcript is detected predominantly in fast muscle fibers (Hughes et al., 1993) . These fiber type differences arise from both the endogenous gene ET AL.
programs of primary and secondary muscle fibers and the action of exogenous influences on skeletal muscle such as innervation and serum hormone levels.
In addition to the MyoD family of myogenic regulators, other nuclear protein genes have been cloned that are known to control skeletal muscle development. Of these, the best characterized are the Myocyte Enhancer Factor 2 ( MEFZ) genes, which are members of the MADS box multigene family of transcription factors (see Martin et al., 1994) . MEF2 gene transcripts are first detected in myotomes around d 9 P.c., after both myf-5 and myogenin mRNAs are expressed (Edmondson et al., 1994) . The MEFB gene transcripts are alternatively spliced. MEF2C is highly enriched in skeletal muscle and brain, and the MEF2D gene contains a n exon that is muscle-specific . MEF2A and MEF2D mRNAs are detected in myotomes a t lower levels than that of MEF2C at 9.5 d p.c. (Edmondson et al., 1994) .
Between 10 and 12 d p.c. all three of the MEFB genes are expressed throughout developing premuscle masses (summarized in Table 1A ). At 13.5 d px., MEF2C gene transcripts are localized predominantly at the ends of developing myofibers ( Figure 3A MEF2C is most highly expressed in nuclei of myoblasts that have most recently fused at the ends of the myotubes. Unlike MyoD, MEF2 gene transcripts are not restricted to striated muscle cells (Figure 3 ) .
A third multigene family that has been implicated in the regulation of skeletal myogenesis consists of the two proto-oncogenes, ski and sno (reviewed in Sutrave and Hughes, 1991) . Both of these genes have the capacity to convert quail embryo fibroblasts to muscle cells when they are overexpressed in tissue culture cells. In situ hybridization analysis of the pattern of cski gene expression in normal mouse embryos has shown that these mRNAs are expressed in all embryonic cells, but the level of expression is elevated in skeletal muscle cells between 12 and 16 d p.c. ; summarized in Table 1A) . sno gene transcripts are also detected above background levels in skeletal muscle a t this time (Kim et al., 1994) . It is not clear whether these nuclear factors bind DNA directly or whether they regulate gene expression a t the level of protein-protein interaction.
Cardiac Muscle Differentiation in the Mouse Embryo
The heart becomes functional earlier than skeletal muscle in mouse embryonic development. Between 7.5 and 8 d p.c. two cardiac primordia fuse a t the midline to form a primitive cardiac tube. The first contractions of the myocardium can be observed a t this time (Rugh, 1990) . The heart undergoes a complex series of morphogenetic events to form an S-shaped structure with a common atrium and a common ventricle by 9.5 d p.c. (Theiler, 1989) . As development proceeds, the ventricle forms trabeculae, and ventricular myocytes proliferate more rapidly than atrial myocytes. The atrium and ventricle undergo septation to form four chambers, and valves develop. Specialized myocytes form the nodes and the conduction system of the heart (reviewed in Lyons, 1994) .
Prior to the fusion of the cardiac primordia, the promyocardium begins to express the homeobox-containing gene Nkx-2.5 (Lints et al., 1993) . These gene transcripts are detected by in situ hybridization prior to contractile protein mRNAs, suggesting that Nkx-2.5 protein may regulate the expression of cardiac actin and myosin genes (whose embryonic expression pattern is summarized in Table 2B ). Nkx-2.5 continues t o be expressed in the heart throughout development (summarized in Table 2A ), but it is not restricted to the heart. After targeted mutagenesis of Nkx-2.5 in transgenic mice, a beating cardiac tube forms in homozygous embryos, but heart morphogenesis does not progress beyond the looping stage, and embryos die after 9 d p.c. (Harvey et al., 1994) .
A second transcription factor gene that is expressed in the promyocardium a t 7.5 d p.c. is MEF2C (Edmondson et al., 1994) . This member of the MADS family of transcriptional regulators has a n AT-rich consensus DNA binding sequence that is located in the promoter of many muscle-specific genes (see references in Martin et al., 1994) that are expressed in both cardiac and skeletal muscle. By 8.0 d P.c., MEF2A and MEFBD mRNAs are also detected in cardiac myocytes, but at lower levels than that of MEF2C. These genes continue to be detected in cardiac muscle a t 13.5 d (Figure 3A ,B) but their levels of expression are diminished compared to those a t earlier stages (summarized in Table 2A ). At the end of gestation, these mRNA levels have dropped close to the limit of detection of the in situ hybridization technique.
A common property of MADS domain DNA binding proteins, such as the MEF2 factors, is their ability to cooperate with other transcriptional regulators to control gene expression (see Martin et al., 1994) . It is likely that the MEF2 proteins in the myocardium interact with homeobox-containing proteins such as Nkx-2.5 and MHox to regulate the contractile protein genes expressed in the developing heart (summarized in Table 2B ).
At 8.0 d P.c., most cardiac-specific structural protein mRNAs are expressed at high levels in all of the Ito et al. (1995); Lyons (1994) . bThe pattern of expression is the same in atrial muscle
myocytes in the cardiac tube (Lyons et al., 1990b) . At 9.5 d, myosin heavy chain P gene transcripts are down-regulated in atrial myocytes when a common atrium forms. At 11.5 d, myosin light chain 1 ventricular mRNA is down-regulated in atrial myocytes as a n interventricular septum forms. These patterns of regional specialization of myocytes during heart morphogenesis (summarized in Table 2B ) may be explained in part by developmental changes in the interaction of such transcription factors as Nkx-2.5, MHox, GATA-4, and the MEF2 family of nuclear proteins. Interaction of nuclear proteins can be altered by such post-transcriptional modifications as phosphorylation or alternative splicing of primary gene transcripts. As mentioned above, the MEFB gene transcripts undergo alternative splicing .
patterns of transcription factor and contractile protein gene expression during embryogenesis. These changes are often associated with muscle morphogenetic events during embryonic growth. Alterations in gene expression patterns, such as the onset of distinguishable skeletal muscle fiber types, often prefigure the mature phenotype of postnatal muscle. Although many of the same structural protein genes are expressed in cardiac and skeletal muscle, the transcriptional factor complexes that regulate these genes are not identical. The MEFB family of transcriptional regulators and MHox are present in both types of muscle, but the MyoD family of myogenic regulators and the proto-oncogenes ski and sno, which are important in skeletal muscle development, are not detectable in myocardium.
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